Creo Medical Group PLC (LON:CREO - Get Free Report)'s share price was up 17.8% during mid-day trading on Wednesday . The company traded as high as GBX 16.20 ($0.22) and last traded at GBX 16.20 ($0.22). Approximately 8,278,319 shares traded hands during mid-day trading, an increase of 510% from the average daily volume of 1,356,147 shares. The stock had previously closed at GBX 13.75 ($0.19).
Creo Medical Group Price Performance
The company's 50-day moving average is GBX 11.09 and its two-hundred day moving average is GBX 14.85. The company has a debt-to-equity ratio of 29.96, a current ratio of 3.24 and a quick ratio of 2.19. The firm has a market cap of £60.64 million, a P/E ratio of -2.37 and a beta of 0.86.
Creo Medical Group (LON:CREO - Get Free Report) last posted its quarterly earnings data on Monday, May 19th. The company reported GBX (8) (($0.11)) earnings per share for the quarter. Creo Medical Group had a negative return on equity of 41.79% and a negative net margin of 73.93%. Sell-side analysts anticipate that Creo Medical Group PLC will post -10.0800005 EPS for the current fiscal year.
About Creo Medical Group
(
Get Free Report)
Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.
The Company's vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.
Further Reading
Before you consider Creo Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Creo Medical Group wasn't on the list.
While Creo Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
